Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology | Family Medicine
Disease Category: Diabetes Mellitus, Type 1
Location: United States, NY
Clinical Trial Details
Research Study Summary
New Onset Type 1 Diabetes: Role of Exenatide
The main purpose of this study is to see if the study medication Byetta improves after meal blood sugars in kids and adults with newly diagnosed Type 1 Diabetes. We will also compare how quickly food leaves the stomach in healthy controls when compared to the kids with diabetes getting the medication during the study. Study includes 4 outpatient visits over a 4-5 month period for kids with diabetes. Kids with diabetes will be compensated to a total of 570 dollars.
Patient Inclusion Criteria:
- Between 12 and 18 years of age
- Diagnosed with Type 1 Diabetes within the past 3 months
Patient Exclusion Criteria:
- Younger than 12 years of age
- Older than 18 years of age
- Have not been diagnosed with Type 1 Diabetes
To Learn more
Both Male and Female
Date Last Changed:
October 16, 2014
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.